Wakamoto Pharmaceutical Co Ltd (4512)

Tokyo
Currency in JPY
329.0
-13.0(-3.80%)
Closed
4512 Scorecard
Full Analysis
Suffers from weak gross profit margins
Fair Value
Day's Range
329.0343.0
52 wk Range
209.0377.0
Key Statistics
Edit
Bid/Ask
329.00 / 332.00
Prev. Close
342
Open
336
Day's Range
329-343
52 wk Range
209-377
Volume
213.2K
Average Vol. (3m)
1.9M
1-Year Change
48.9%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4512 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield
Show more

Wakamoto Pharmaceutical Co Ltd Company Profile

Wakamoto Pharmaceutical Co.,Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation; and Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.

Employees
403
Market
Japan

Compare 4512 to Peers and Sector

Metrics to compare
4512
Peers
Sector
Relationship
P/E Ratio
0.0x−1.9x−0.5x
PEG Ratio
0.000.050.00
Price / Book
0.0x1.8x2.6x
Price / LTM Sales
0.0x2.4x3.0x
Upside (Analyst Target)
0.0%87.0%57.1%
Fair Value Upside
Unlock12.7%10.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.87%
Dividend Yield
0.91%
Industry Median 2.29%
Annualized Payout
3.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 05, 2025
EPS / Forecast
3.53 / --
Revenue / Forecast
2.00B / --
EPS Revisions
Last 90 days

People Also Watch

950.0
5288
-1.35%
157.0
4978
+3.29%
1,255.0
4611
+0.56%
851.0
2198
+0.24%
473.0
7971
+0.85%

FAQ

What Is the Wakamoto Pharmaceutical (4512) Stock Price Today?

The Wakamoto Pharmaceutical stock price today is 329.00

What Stock Exchange Does Wakamoto Pharmaceutical Trade On?

Wakamoto Pharmaceutical is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Wakamoto Pharmaceutical?

The stock symbol for Wakamoto Pharmaceutical is "4512."

Does Wakamoto Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Wakamoto Pharmaceutical dividend yield is 0.91%.

What Is the Wakamoto Pharmaceutical Market Cap?

As of today, Wakamoto Pharmaceutical market cap is 11.55B.

What is Wakamoto Pharmaceutical Earnings Per Share?

The Wakamoto Pharmaceutical EPS is 6.87.

What Is the Next Wakamoto Pharmaceutical Earnings Date?

Wakamoto Pharmaceutical will release its next earnings report on May 14, 2025.

From a Technical Analysis Perspective, Is 4512 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.